AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05854524 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic exercise
Description: The intervention is exercise and there are no drugs or devices used in this trial. The exercise consists of two intensity levels of a 30-minute aerobic exercise intervention with both arms crossing over to both conditions: low intensity exercise (60-70% of estimated maximum heart rate (EMRH)) and moderate-vigorous intensity exercise (75-85% of EMHR).
Study NCT04812522 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Clean Cut program
Description: Clean Cut, is an adaptive, multimodal surgical infection prevention program that integrates perioperative process improvement and patient outcomes measurement using process mapping, training and improved management practices, and compliance with critical standards of surgical antisepsis
Study NCT06358092 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hepatic venous pressure gradient
Description: HVPG is a measurement used to assess portal hypertension, a condition characterized by increased blood pressure in the portal vein, which carries blood from the digestive organs to the liver. HVPG measurement involves inserting a catheter into the hepatic vein via jugular vein puncture to directly measure the pressure within the liver. By comparing the pressure in the hepatic vein with that in the portal vein, HVPG provides valuable information about the severity of portal hypertension and helps in predicting clinical outcomes in patients with liver cirrhosis and related conditions. HVPG measurements are crucial in guiding treatment decisions, assessing treatment response, and predicting the risk of complications such as variceal bleeding and liver failure.
Study NCT06078033 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mobilization with movement
Description: Sustained neutral apophyseal glide (SNAG) mobilization with movement applied to targeted vertebra while patients performed their painful movement.
Study NCT06078033 — intervention group
Intervention type: BIOLOGICAL
Group type: SHAM_COMPARATOR
Intervention: Sham mobilization with movement
Description: Manual contact (without any pressure) applied to targeted vertebra while patients performed their painful movement.
Study NCT04891900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2450/Anlotinib hydrochloride/Oxaliplatin/Capecitabine
Description: Initial treatment (6 cycles)：~1. TQB2450：1200 mg , Day 1 ivgtt ,once every 3 weeks~2. Anlotinib: 10 mg/day orally ，from days 1 to 14 in a 21-day cycle~3. Oxaliplatin: 130 mg / m2, Day 1 ivgtt ,once every 3 weeks~4. Capecitabine: 1000 mg / m2, orally, twice a day (once in the morning and once in the evening), from days 1 to 14 in a 21-day cycle Maintenance treatment：~1）TQB2450: 1200 mg , Day 1 ivgtt , once every 3 weeks 2）Anlotinib: 10 mg/day orally , from days 1 to 14 in a 21-day cycle
Study NCT06358092 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Two-Dimensional Shear Wave Elastography
Description: 2D-SWE is a non-invasive imaging technique used to assess tissue stiffness, particularly in the liver. This technology utilizes ultrasound to generate shear waves within the tissue being examined. By measuring the speed of these shear waves as they propagate through the tissue, 2D-SWE can provide quantitative information about tissue elasticity or stiffness. In the context of liver disease, including cirrhosis and fibrosis, 2D-SWE is valuable for evaluating the degree of liver stiffness, which correlates with the severity of liver fibrosis. This information aids in diagnosis, staging, and monitoring of liver diseases, allowing for early detection of complications and assessment of treatment response. Compared to traditional biopsy-based methods, 2D-SWE offers the advantage of being non-invasive, rapid, and repeatable, making it a preferred modality for assessing liver stiffness in clinical practice.
Study NCT05870033 — intervention group
Intervention type: DEVICE
Intervention: Electromyography (EMG) measurement
Description: Electromyography (EMG) measurement of m. quadriceps femoris and semitendinosus muscle during static functional tasks
Study NCT04754776 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ChAdOx1 RVF
Description: Single dose of ChAdOx1 RVF
Study NCT04956458 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar motion style acupuncture treatment
Description: Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation
Study NCT04956458 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Korean medical treatment
Description: acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine
Study NCT06376240 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pyridoxamine 300mg per day
Description: oral supplement
Study NCT06376240 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo 300mg placebo per day
Description: oral supplement
Study NCT04706143 — intervention group
Intervention type: BIOLOGICAL
Intervention: COVID-19 Vaccines
Description: different available vaccines: live inactivated, mRNA and viral vector vaccines
Study NCT05417308 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Minoxidil
Description: Applied topically
Study NCT05417308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minoxidil
Description: Given PO
Study NCT05417308 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05417308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05417308 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05417308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04436965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Patients in both arms received concurrent cisplatin chemotherapy:100 mg/m² cisplatin given intravenously every 3 weeks on days 1, 22 concurrently with radiotherapy.
Study NCT04436965 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity Modulated Radiation Therapy
Description: Patients in both arms received Intensity Modulated Radiation Therapy:All target volumes were outlined slice by slice on the axial contrast-enhanced CT with MR fusion images in the treatment planning system. The target volumes were defined in accordance with the International Commission on Radiation Units and Measurements Reports 83. The prescribed dose was 70-72 Gy to PTVnx (Planning target volume of the primary tumor), 64-70 Gy to PTVnd (Planning target volume of the cervical lymph node),60- 64Gy to PTV1 (Planning target volume 1), and 54-58 Gy to PTV2 (Planning target volume 2) in 30-32 fractions. The details of dose limits for organs at risk were based on the study 0225 from The Radiation Therapy Oncology Group (RTOG 0225).
Study NCT05170178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: inclusion and familiarization
Description: * presentation of the study purpose and the protocol to the volunteer~* clinical examination to check inclusion and exclusion criteria~* Familiarization with the crying of one assigned baby, by listening to several bath cries from this baby
Study NCT05170178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: fMRI acquisition and closure
Description: * Second phase of familiarization, listening again to bath cries of their assigned baby. These cries will be different from those listened during the first familiarization phase.~* MRI acquisition: after acquisition of the anatomical images (5 min), the subjects will listen to 64 cries divided into 4 functional MRI sessions of 10 minutes each. The cries will be those of their baby or of unknown babies, evoked in a painful (vaccination) or a non-painful (bath) situation, presented in a pseudo-random order. Participants will be asked to assess whether they recognize their baby (yes/no) and whether they recognize a pain cry (yes/no).~* debriefing~* Protocol ending
Study NCT04436965 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy
Description: Patients in both arms received Intensity Modulated Radiation Therapy:All target volumes were outlined slice by slice on the axial contrast-enhanced CT with MR fusion images in the treatment planning system. The target volumes were defined in accordance with the International Commission on Radiation Units and Measurements Reports 83. The prescribed dose was 70-72 Gy to PTVnx (Planning target volume of the primary tumor), 64-70 Gy to PTVnd (Planning target volume of the cervical lymph node),60- 64Gy to PTV1 (Planning target volume 1), and 54-58 Gy to PTV2 (Planning target volume 2) in 30-32 fractions. The details of dose limits for organs at risk were based on the study 0225 from The Radiation Therapy Oncology Group (RTOG 0225).
Study NCT05705245 — intervention group
Intervention type: OTHER
Intervention: recruitment
Description: Automated alveolar recruitment menouever applied during mechanical ventilation in the intraoperative period
Study NCT05213923 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ED Sepsis Tracking Sheet
Description: Implementation of an ED Sepsis Tracking Sheet. This sheet will track time of patient presentation, time of High-Acuity Medical Response (HAMR) page, time of bilateral 18g or larger IV access, time of initial lactate, time two sets of blood cultures were sent, time antibiotics were administered as well as which antibiotics and what dose, time initial IV fluid bolus was completed, time repeat lactate was sent, timing of post-IV-fluid bolus vital signs, as well as the presence of persistent hypotension following this IV fluid bolus and whether or not vasopressors were applied.
Study NCT05107232 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MRI
Description: MRI
Study NCT05931328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thiotepa combined with pomalidomide
Description: thiotepa combined with pomalidomide: thiotepa 30mg/m2,intravenously guttae, on day 1; pomalidomide 12mg orally daily for 2 weeks. A chemotherapy cycle lasts for 3 weeks.
Study NCT06115265 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: KDDP and NDPP will deliver identical comprehensive lifestyle counseling and follow up to participants, but dietary interventions in each group will differ, with KDDP participants receiving a ketogenic diet and NDPP participants receiving a low fat diet.
Study NCT06115265 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Fat diet
Description: KDDP and NDPP will deliver identical comprehensive lifestyle counseling and follow up to participants, but dietary interventions in each group will differ, with KDDP participants receiving a ketogenic diet and NDPP participants receiving a low fat diet.
Study NCT06160063 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education intervention
Description: Board game was created in line with current literature. In each interview, it is expected that the child's negative behaviors will be transformed into positive behaviors.
Study NCT05768152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RLRL
Description: RLRL will be performed twice per day with an interval of at least 4 hours, each treatment last 3 minutes, in addition to single vision spectacles with power for correcting distance refraction.
Study NCT04722471 — intervention group
Intervention type: DRUG
Intervention: Vaginally administered progesterone
Description: The artificial endometrial preparation for an embryo transfer with the use of 400 mg vaginal tablet (one tablet twice a day) or 200 mg (two tablets twice a day)
Study NCT06251791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy+ IMT
Description: Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day. Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day. In this group addition to conventional physiotherapy inspiratory muscle training will be performed with the threshold-loaded inspiratory muscle training device, starting at 30% of the maximum inspiratory mouth pressure value, during 5 days, in 2 sessions, 4 sets per day, 6-8 breaths in each set and 2 minutes of rest between sets.
Study NCT06251791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy
Description: Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day. Conventional Physiotherapy to contain breathing and thoracal expansion exercises, bronchial hygiene techniques and gradual mobilization in 1 time a day.
Study NCT05097534 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: iDSMES
Description: Intensive Diabetes Self-Management Education and Support combined with Addressing Social Determinants of Health
Study NCT05097534 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care
Description: Standard of Care for patients with type 2 diabetes
Study NCT06508762 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-993
Description: Tablet and Suspension for Oral Administration.
Study NCT06215404 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Liberal group
Description: Fluid challage to keep stroke volume variation \< 10%
Study NCT06215404 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: restrictive group
Description: Fluid challage to keep stroke volume variation \< 18%
Study NCT05184374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gonadorelin
Description: GnRH pump pulse subcutaneous injection of gonadorelin in a month
Study NCT06162156 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Back massage
Description: For the intervention group, massage will be given to the participant's back area by the researcher for 20 minutes, 12 hours after the cesarean birth. Preliminary data forms will be filled out by the participant before the massage. One hour after the massage, 'Visual Analog Scala' and 'Physiological Parameter Form' data will be filled in again. The final data forms will be filled out by the participant 24 hours after the cesarean birth, that is, 12 hours after the back massage.
Study NCT02025712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exemestane
Description: Commercially available exemestane was supplied to sites as 25-mg tablets according to local regulations.
Study NCT02025712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus
Description: Everolimus was administered by continuous oral dosing of two 5-mg tablets or one 10-mg tablets.
Study NCT05652153 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Single-/paired-pulse transcranial magnetic stimulation
Description: Single-/paired-pulse transcranial magnetic stimulation (sp/ppTMS) is a technique for noninvasive assessment of brain physiology by delivering single or paired magnetic stimuli to the scalp with an electromagnetic coil. This results in transient induction of cortical electrical activity, which can be measured as evoked potentials by electromyography (EMG) and electroencephalography (EEG). Note that sp/ppTMS is used for neurophysiologic measurements; it is distinct from other TMS applications such as repetitive TMS, which can be used as interventions.
Study NCT05457088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1.5 protein
Description: dietary plan having dietary protein of 1.5 gr/kg/day
Study NCT05457088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 0.8 protein
Description: dietary plan having dietary protein of 0.8 gr/kg/day
Study NCT05024903 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Serious illness medical planning plus the novel e-health platform (PWG 2.0)
Description: PWG 2.0 consists of the following components:~1. A diagnostic questionnaire, Preparedness for the Future Questionnaire and bench-marked report that helps users assess their strengths, weaknesses and opportunities for improvement.~2. A comprehensive e-workbook that helps users understand the science behind personal behavior change.~3. Links to webpages with additional e-workbooks and curated content aimed to help users progress on the 30 different attitudes, behaviors, and activities that portend for a better future (topics listed in Appendix A).~4. E-messages delivered via emails (via text an option for those that prefer) with tailored content designed to provide multiple nudges to guide the user to progress through our content.~5. Monthly newsletter with current topics and issues related to the 30 topics and behavior change in general.~6. A virtual consultation with Dr. Heyland, creator of PWG and principal investigator.
Study NCT05024903 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Participants are not planning for their future (PWG 2.0) or using the e-health platform
Study NCT05501951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tDCS stimulation
Description: The transcranial direct current stimulation (tDCS) method has emerged in the recent years as a non-invasive, safe, cheap, convenient and effective means to modulate brain functions and behaviours
Study NCT05501951 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: For the sham group, the electrode positioning will be randomly allocated to be identical to either the DLPFC or the OFC group, and active stimulation will be delivered for the first 30 seconds only
Study NCT04772781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S (+) - Ibuprofen
Description: S (+) - Ibuprofen + placebo of Ibuflex®
Study NCT04772781 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuflex®
Description: Ibuflex® + placebo of S (+) - Ibuprofen
Study NCT05126628 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Proxalutamide
Description: Proxalutamide 300mg q.d.(3 tablets of 100mg each) for 14 days.
Study NCT05126628 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 3 tablets q.d. for 14 days
Study NCT05254873 — intervention group
Intervention type: OTHER
Intervention: Long term follow-up
Description: Long term follow-up for patient who completed the EYE-TAR(MA) study.
Study NCT05590026 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pectointercostal and ESP block
Description: Both Pectointercostal at between 4th and 5th costa and ESP block will apply at thoracal 6 level to the patient.
Study NCT05590026 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pectointercostal and ESP block
Description: Both Pectointercostal at between 4th and 5th costa and ESP block will apply at thoracal 6 level to the patient.
Study NCT04760717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spironolactone Pill
Description: Participants randomized to the Spironolactone arm will be receiving Spironolactone in addition to their normal routine blood pressure treatment.
Study NCT06155539 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05453045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albendazole
Description: tablet administration after a meal contaning approximate 15 g of fat
Study NCT05974319 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry heat application
Description: Dry heat application: The region where the invasive intervention will be performed will be determined by the nurse in charge of the shift. The researcher will heat the thermoregulated electric pad and set it to 42°C. After making sure that there are no contraindications in the application of the electric pad device, a dry heat of 42°C will be applied to the determined area with the electric pad for 5 minutes.
Study NCT05974319 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry cold application
Description: Dry cold applicaiton: The region where the invasive intervention will be performed will be determined by the nurse in charge of the shift. After the researcher is sure that there are no contraindications in the application of the gel pad, dry cold will be applied to the determined area with the gel pad for 3 minutes.
Study NCT06527534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Filgotinib
Description: Patients will receive pills of Filgotinib 200 mg qd for 12 weeks
Study NCT06527534 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adalimumab
Description: Patients will receive subcutaneous injections of Adalimumab 40 mg q2wk for 12 weeks
Study NCT05199961 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Health Coaching
Description: The digital health coaching program consists of weekly calls and delivery of evidence-based content across health and wellness domains (e.g. nutrition, exercise, physical, emotional and financial health) up to 4 times weekly via text, email or mobile application. The program is 6-months in duration and designed for engagement following CAR T cell infusion.
Study NCT05378061 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pituitary adenylate cyclase activating polypeptide-38
Description: Study participants will be allocated to receive continuous intravenous infusion of 10 pmol/kg/min PACAP-38.
Study NCT05378061 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study participants will be allocated to receive continuous intravenous infusion of 20 mL placebo (isotonic saline).
Study NCT05342376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine Hydrochloride
Description: The parturients will receive 10 micro-gram Dexmedetomidine diluted in 02 ml normal saline to be administered intravenously over 10 minutes after umbilical cord is clamped..